21:26 EDT Cathie Wood’s ARK Investment buys 35K shares of Recursion Pharmaceuticals (RXRX) today
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on RXRX:
- Cathie Wood Capitalizes on Pullback in Tempus AI to Buy Additional Stock Worth $14.4M
- Recursion Pharmaceuticals’ Earnings Call Highlights Growth
- Recursion Pharmaceuticals Reports Mixed 2024 Financial Results
- Cathie Wood’s ARK Investment buys 653K shares of Recursion Pharmaceuticals today
- Strong Buy Recommendation for Recursion Pharmaceuticals: Leading Techbio Innovator with Robust Financials and Strategic AI Integration